20 November 2026, 13:00
Multimodal imaging of malaria parasite formation and migration
...
Speaker(s): Friedrich Frischknecht, University Medical Centre Heidelberg, Germany
Host: Jonas Albers (Duke Group)
Place: Seminar Room 48e
EMBL Hamburg
At EMBL, experts from institutes throughout the world speak on a wide range of scientific and technical topics
20 November 2026, 13:00
...
Speaker(s): Friedrich Frischknecht, University Medical Centre Heidelberg, Germany
Host: Jonas Albers (Duke Group)
Place: Seminar Room 48e
EMBL Hamburg
30 November 2026, 11:00
Description In this webinar two speakers who moved from academic research into technology transfer and patent law will share insights into their career paths and current roles Through presentations followed by a moderated Q A you ll hear about their transitions what their work involves and their perspectives on these two career areas Register via https embl org zoom us webinar register WN 938z0r eRgy1E9jSvP5kFw registration Please note that the talk will yes not be recorded For the FAQ section as a zoom participant please use either the chat function the host will read out your question or the raise your hand function and turn on your microphone... In this webinar, two speakers who moved from academic research into technology transfer and patent law will share insights into their career paths and current roles. Through presentations followed by a moderated Q&A, you’ll hear about their transitions, what their work involves and their perspectives on these two career areas. Register via https://embl-org.zoom.us/webinar/register/WN_938z0r-eRgy1E9jSvP5kFw#/registration Please note that the talk will yes/not be recorded.*For the FAQ section, as a zoom participant, please use either the chat function (the host will read out your question) or the “raise your hand” function and turn on your microphone.
Speaker(s): Diana Domínguez Rodríguez, Innovation & Business Manager at Centre for Genomic Regulation (CRG), Spain, Spain | Saba Safdar, European Patent Attorney, Gevers
Host: EMBL Fellows' Career Service
Place: Virtual
Virtual, Virtual
In this webinar, two speakers who moved from academic research into technology transfer and patent law will share insights into their career paths and current roles. Through presentations followed by a moderated Q&A, you’ll hear about their transitions, what their work involves and their perspectives on these two career areas.
Register via https://embl-org.zoom.us/webinar/register/WN_938z0r-eRgy1E9jSvP5kFw#/registration
Please note that the talk will yes/not be recorded.
*For the FAQ section, as a zoom participant, please use either the chat function (the host will read out your question) or the “raise your hand” function and turn on your microphone.
4 December 2026, 11:00
Description AbstractDeciphering the intricate mechanisms underlying reprogramming in cancer cells is a crucial challenge in oncology as it holds the key to advancing our ability to diagnose and treat cancer patients For this reason comprehensive and patient specific multi omic characterization of tumor specimens has become increasingly common in clinical practice Despite these efforts no effective approach for identifying the molecular mechanisms dysregulated at patient resolution level has been developed nor have these advances been effectively employed to define personalized therapeutic regimens The main shortcoming is the absence of a robust computational framework to exploit such information by integrating and interpreting the available multi dimensional data to drive translational solutions To fill this gap we developed PatientProfiler a computational pipeline that leverages causal interaction data annotated in our in house curated resource SIGNOR to address how the genetic and molecular background of each individual patient contributes to the establishment of a malignant phenotype PatientProfiler allows for multi omic data analysis and standardization generation of patient specific mechanistic models of signal transduction and the extraction of network based prognostic biomarkers We recently applied PatientProfiler to genomics transcriptomics proteomics and phosphoproteomics data from 105 treatment nai ve Pancreatic Ductal Adenocarcinoma PDAC biopsies extracted from the CPTAC portal By this approach we were able to generate a collection of patient specific mechanistic models of PDAC tumorigenesis and progression These mechanistic models can recapitulate in a genotype specific context the activation status of key signal transduction proteins based on the regulatory interactions that affect their activities Integration of these models with clinical data made it possible to stratify PDAC patients into eight subgroups defined by the key activity of signal transduction effectors Importantly we demonstrated that these stratification groups have a prognostic value in the CPTAC cohort and also in two independent cohorts of PDAC patients revealing the translational impact of the approach About the speakerLivia Perfrtto obtained her PhD at the University of Rome Tor Vergata in 2014 in Prof Cesareni s group and stayed on for three more years coordinating the development of SIGNOR a new resource supporting the experimental investigation of signalling networks In 2017 she moved to EBI working as a bioinformatician and database curator on the IntAct and Complex Portal databases In November 2020 she took up a new position funded by Human Technopole Milan as scientific consultant and database coordinator She became group leader in 2022 Since 2025 She is Associate Professor at Sapienza University Rome Her group is interdisciplinary built on close collaboration between a database unit and a bioinformatics unit The database unit develops curates and maintains SIGNOR while the bioinformatics unit designs algorithms and computational pipelines that use SIGNOR s annotated knowledge to interpret and contextualize omic data Meet the speakerTo meet with the speaker informally after the talks please reach out to Fabio Petroni We especially encourage predocs and postdocs to take advantage of this opportunity... AbstractDeciphering the intricate mechanisms underlying reprogramming in cancer cells is a crucial challenge in oncology as it holds the key to advancing our ability to diagnose and treat cancer patients. For this reason, comprehensive and patient-specific multi-omic characterization of tumor specimens has become increasingly common in clinical practice. Despite these efforts, no effective approach for identifying the molecular mechanisms dysregulated at patient-resolution level has been developed, nor have these advances been effectively employed to define personalized therapeutic regimens. The main shortcoming is the absence of a robust computational framework to exploit such information by integrating and interpreting the available multi-dimensional data to drive translational solutions.To fill this gap, we developed PatientProfiler, a computational pipeline that leverages causal...
Speaker(s): Livia Perfetto, Sapienza University, Italy
Place: Conf Room/Building 14
EMBL Rome
Abstract
Deciphering the intricate mechanisms underlying reprogramming in cancer cells is a crucial challenge in oncology as it holds the key to advancing our ability to diagnose and treat cancer patients. For this reason, comprehensive and patient-specific multi-omic characterization of tumor specimens has become increasingly common in clinical practice. Despite these efforts, no effective approach for identifying the molecular mechanisms dysregulated at patient-resolution level has been developed, nor have these advances been effectively employed to define personalized therapeutic regimens. The main shortcoming is the absence of a robust computational framework to exploit such information by integrating and interpreting the available multi-dimensional data to drive translational solutions.
To fill this gap, we developed PatientProfiler, a computational pipeline that leverages causal interaction data, annotated in our in-house curated resource, SIGNOR, to address how the genetic and molecular background of each individual patient contributes to the establishment of a malignant phenotype. PatientProfiler allows for multi-omic data analysis and standardization, generation of patient-specific mechanistic models of signal transduction, and the extraction of network-based prognostic biomarkers. We recently applied PatientProfiler to genomics, transcriptomics, proteomics and phosphoproteomics data from 105 treatment-naïve Pancreatic Ductal Adenocarcinoma (PDAC) biopsies, extracted from the CPTAC portal. By this approach we were able to generate a collection of patient-specific mechanistic models of PDAC tumorigenesis and progression. These ‘mechanistic models’ can recapitulate, in a genotype-specific context, the activation status of key signal transduction proteins based on the regulatory interactions that affect their activities. Integration of these models with clinical data made it possible to stratify PDAC patients into eight subgroups, defined by the key activity of signal transduction effectors. Importantly, we demonstrated that these stratification groups have a prognostic value in the CPTAC cohort and also in two independent cohorts of PDAC patients, revealing the translational impact of the approach.
About the speaker
Livia Perfrtto obtained her PhD at the University of Rome "Tor Vergata" in 2014, in Prof. Cesareni's group, and stayed on for three more years, coordinating the development of SIGNOR, a new resource supporting the experimental investigation of signalling networks. In 2017 she moved to EBI, working as a bioinformatician and database curator on the IntAct and Complex Portal databases. In November 2020 she took up a new position funded by Human Technopole (Milan), as scientific consultant and database coordinator. She became group leader in 2022. Since 2025, She is Associate Professor at Sapienza University, Rome.
Her group is interdisciplinary, built on close collaboration between a database unit and a bioinformatics unit. The database unit develops, curates, and maintains SIGNOR, while the bioinformatics unit designs algorithms and computational pipelines that use SIGNOR's annotated knowledge to interpret and contextualize -omic data.
Meet the speaker
To meet with the speaker informally after the talks, please reach out to Fabio Petroni. We especially encourage predocs and postdocs to take advantage of this opportunity.
15 December 2026, 14:00
Description Prokaryotic transcription and translation can be coupled enabling mutual regulation However how RNA polymerase RNAP recruits ribosomes to form coupled complexes expressomes remains unclear Using cryo EM we visualize the continuum of states during co transcriptional translation initiation with initiation factors IF1 IF2 IF3 fMet tRNAfMet and transcription factors NusA and NusG We reveal the stepwise recruitment of initiation factors fMet tRNAfMet and progressive mRNA accommodation capturing the initial mRNA delivery state where ribosomal protein bS1 guides mRNA for anti Shine Dalgarno pairing multiple pre accommodation intermediates and the final accommodated complex IF3 and IF1 assist 30S subunit activation and stabilize mRNA accommodation intermediates IF2 adopts dual conformations to monitor the mRNA binding channel ensuring mRNA loading while preventing premature 50S subunit joining NusA and NusG drive the reaction toward an RNAP coupled 70S initiation complex concluding the pathway These snapshots provide a structural framework for understanding co transcriptional translation initiation and for the roles of auxiliary factors... Prokaryotic transcription and translation can be coupled, enabling mutual regulation. However, how RNA polymerase (RNAP) recruits ribosomes to form coupled complexes (expressomes) remains unclear. Using cryo-EM, we visualize the continuum of states during co-transcriptional translation initiation with initiation factors (IF1, IF2, IF3), fMet-tRNAfMet, and transcription factors NusA and NusG. We reveal the stepwise recruitment of initiation factors, fMet-tRNAfMet, and progressive mRNA accommodation - capturing the initial “mRNA delivery state” where ribosomal protein bS1 guides mRNA for anti-Shine-Dalgarno pairing, multiple pre-accommodation intermediates, and the final accommodated complex. IF3 and IF1 assist 30S subunit activation and stabilize mRNA accommodation intermediates. IF2 adopts dual conformations to monitor the mRNA-binding channel, ensuring mRNA loading while preventing...
Speaker(s): Albert Weixlbaumer, IGBMC Strasbourg, France
Host: Olivier Duss, MSB Unit, EMBL Heidelberg
Place: Room 202
EMBL Heidelberg
Prokaryotic transcription and translation can be coupled, enabling mutual regulation. However, how RNA polymerase (RNAP) recruits ribosomes to form coupled complexes (expressomes) remains unclear. Using cryo-EM, we visualize the continuum of states during co-transcriptional translation initiation with initiation factors (IF1, IF2, IF3), fMet-tRNAfMet, and transcription factors NusA and NusG. We reveal the stepwise recruitment of initiation factors, fMet-tRNAfMet, and progressive mRNA accommodation - capturing the initial “mRNA delivery state” where ribosomal protein bS1 guides mRNA for anti-Shine-Dalgarno pairing, multiple pre-accommodation intermediates, and the final accommodated complex. IF3 and IF1 assist 30S subunit activation and stabilize mRNA accommodation intermediates. IF2 adopts dual conformations to monitor the mRNA-binding channel, ensuring mRNA loading while preventing premature 50S subunit joining. NusA and NusG drive the reaction toward an RNAP-coupled 70S initiation complex, concluding the pathway. These snapshots provide a structural framework for understanding co-transcriptional translation initiation and for the roles of auxiliary factors.
No matching seminars found; Reset your filters.